Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aytu Biopharma (AYTU) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Aytu Biopharma (AYTU) over the last 17 years, with Q2 2025 value amounting to $0.01.

  • Aytu Biopharma's EPS (Basic) rose 10120.4% to $0.01 in Q2 2025 from the same period last year, while for Jun 2025 it was $0.01, marking a year-over-year increase of 10034.52%. This contributed to the annual value of $0.1 for FY2025, which is 10345.21% up from last year.
  • According to the latest figures from Q2 2025, Aytu Biopharma's EPS (Basic) is $0.01, which was up 10120.4% from -$0.82 recorded in Q2 2024.
  • Over the past 5 years, Aytu Biopharma's EPS (Basic) peaked at $0.01 during Q2 2025, and registered a low of -$35.9 during Q1 2022.
  • For the 5-year period, Aytu Biopharma's EPS (Basic) averaged around -$5.75, with its median value being -$1.12 (2021).
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 611714.29% in 2021, then surged by 10120.4% in 2025.
  • Quarter analysis of 5 years shows Aytu Biopharma's EPS (Basic) stood at -$8.74 in 2021, then surged by 75.4% to -$2.15 in 2022, then soared by 92.93% to -$0.15 in 2023, then plummeted by 439.27% to -$0.82 in 2024, then soared by 101.2% to $0.01 in 2025.
  • Its EPS (Basic) was $0.01 in Q2 2025, compared to -$0.82 in Q2 2024 and -$0.11 in Q1 2024.